267 related articles for article (PubMed ID: 30803073)
1. A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System.
Wu D; Qin M; Xu D; Wang L; Liu C; Ren J; Zhou G; Chen C; Yang F; Li Y; Zhao Y; Huang R; Pourtaheri S; Kang C; Kamata M; Chen ISY; He Z; Wen J; Chen W; Lu Y
Adv Mater; 2019 May; 31(18):e1807557. PubMed ID: 30803073
[TBL] [Abstract][Full Text] [Related]
2. Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy.
Han L; Liu C; Qi H; Zhou J; Wen J; Wu D; Xu D; Qin M; Ren J; Wang Q; Long L; Liu Y; Chen I; Yuan X; Lu Y; Kang C
Adv Mater; 2019 May; 31(19):e1805697. PubMed ID: 30773720
[TBL] [Abstract][Full Text] [Related]
3. Targeting central nervous system pathologies with nanomedicines.
Mizrahy S; Gutkin A; Decuzzi P; Peer D
J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187
[TBL] [Abstract][Full Text] [Related]
4. Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration.
Xu D; Wu D; Qin M; Nih LR; Liu C; Cao Z; Ren J; Chen X; He Z; Yu W; Guan J; Duan S; Liu F; Liu X; Li J; Harley D; Xu B; Hou L; Chen ISY; Wen J; Chen W; Pourtaheri S; Lu Y
Adv Mater; 2019 Aug; 31(33):e1900727. PubMed ID: 31125138
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
Gao H; Pang Z; Jiang X
Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology-based drug delivery for central nervous system disorders.
Nguyen TT; Dung Nguyen TT; Vo TK; Tran NM; Nguyen MK; Van Vo T; Van Vo G
Biomed Pharmacother; 2021 Nov; 143():112117. PubMed ID: 34479020
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticles for drug delivery to the central nervous system.
Patel T; Zhou J; Piepmeier JM; Saltzman WM
Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
[TBL] [Abstract][Full Text] [Related]
8. Agile delivery of protein therapeutics to CNS.
Yi X; Manickam DS; Brynskikh A; Kabanov AV
J Control Release; 2014 Sep; 190():637-63. PubMed ID: 24956489
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Delivery of Rituximab Into Brain and Lymph Nodes Using Timed-Release Nanocapsules in Non-Human Primates.
Qin M; Wang L; Wu D; Williams CK; Xu D; Kranz E; Guo Q; Guan J; Vinters HV; Lee Y; Xie Y; Luo Y; Sun G; Sun X; He Z; Lu Y; Kamata M; Wen J; Chen ISY
Front Immunol; 2019; 10():3132. PubMed ID: 32047498
[TBL] [Abstract][Full Text] [Related]
10. Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis.
Zheng Q; Chen ZX; Xu MB; Zhou XL; Huang YY; Zheng GQ; Wang Y
Drug Deliv; 2018 Nov; 25(1):1617-1633. PubMed ID: 30334462
[TBL] [Abstract][Full Text] [Related]
11. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
Crawford L; Rosch J; Putnam D
J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnologies: a strategy to overcome blood-brain barrier.
De Rosa G; Salzano G; Caraglia M; Abbruzzese A
Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
[TBL] [Abstract][Full Text] [Related]
14. Polymersomes conjugated with des-octanoyl ghrelin for the delivery of therapeutic and imaging agents into brain tissues.
Chen YC; Chiang CF; Chen LF; Liao SC; Hsieh WY; Lin WL
Biomaterials; 2014 Feb; 35(6):2051-65. PubMed ID: 24315575
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics.
Bourganis V; Kammona O; Alexopoulos A; Kiparissides C
Eur J Pharm Biopharm; 2018 Jul; 128():337-362. PubMed ID: 29733950
[TBL] [Abstract][Full Text] [Related]
16. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
Banks WA
Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
[TBL] [Abstract][Full Text] [Related]
17. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
Dilnawaz F; Sahoo SK
Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
[TBL] [Abstract][Full Text] [Related]
19. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
20. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
